Skip to content

Health-related Quality of Life in Rare Kidney Stone

Assessment of Health-related Quality of Life in Rare Kidney Stone Formers in the Rare Kidney Stone Consortium

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02124395
Enrollment
365
Registered
2014-04-28
Start date
2013-08-31
Completion date
2022-07-31
Last updated
2022-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenine Phosphoribosyl Transferase Deficiency, Cystinuria, Dent Disease, Primary Hyperoxaluria

Brief summary

Assessment of Health-related Quality of Life in Rare Kidney Stone Formers in the Rare Kidney Stone Consortium

Detailed description

The purpose of this study is to learn about Health-related Quality Of Life (HRQoL) in patients enrolled in the Rare Kidney Stone Consortium (RKSC) registries. Quality of life studies look at different aspects of both physical and mental components of people's lives. HRQoL data for people affected by kidney stones are not currently available for people followed over time.

Interventions

OTHERHealth-related Quality of Life in Rare Kidney Stone Questionnaire

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
NYU Langone Health
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
5 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Qualify to participate in one of the Rare Kidney Stone Registries. * Be at least 5 years old (for SF-10) * Are able to communicate using the English language * Consent to participate in the study (or assent if under 18 years old) * Have internet access with an email account or a valid home address

Exclusion criteria

None, if inclusion criteria are met

Design outcomes

Primary

MeasureTime frameDescription
Assessment of HRQoL in patients with rare kidney stonesOnce a year for up to 5 years after signed consentAssessment of HRQoL in patients with rare kidney stones. Comparison of HRQoL results between rare kidney stone formers, general population and other populations with relevant chronic diseases

Countries

Iceland, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026